<DOC>
	<DOCNO>NCT00915811</DOCNO>
	<brief_summary>The purpose study determine safety feasibility condition fludarabine , busulphan thymoglobuline patient myelodysplastic syndrome ( MDS ) , myelodysplastic/myeloproliferative disorder ( MDS/MPD ) acute myeloid leukaemia ( AML ) undergo haematopoietic stem cell allograft granulocyte colony-stimulating factor ( G-CSF ) -mobilised peripheral blood stem cell ( PBSC ) ( bone marrow ) HLA compatible sibling donor .</brief_summary>
	<brief_title>Pilot Study Reduced Intensity Haematopoietic Stem Cell Transplantation Patients With Poor Risk Myelodysplastic Syndrome ( MDS ) Acute Myeloid Leukaemia ( AML ) Utilising Conditioning With Fludarabine , Busulphan Thymoglobulin</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Leukemia , Myeloid</mesh_term>
	<mesh_term>Leukemia , Myeloid , Acute</mesh_term>
	<mesh_term>Myelodysplastic Syndromes</mesh_term>
	<mesh_term>Preleukemia</mesh_term>
	<mesh_term>Fludarabine</mesh_term>
	<mesh_term>Fludarabine phosphate</mesh_term>
	<mesh_term>Busulfan</mesh_term>
	<mesh_term>Antilymphocyte Serum</mesh_term>
	<mesh_term>Vidarabine</mesh_term>
	<criteria>Patient Selection 1 . Availability HLA compatible sibling donor 2 . Age &gt; 18 year 3 . Myelodysplastic Syndromes IPSS Intermediate2 High . 4 . Poor risk acute myeloid leukaemia , de novo transform MDS 5 . Ineligibility standard conditioning allograft due age coexist morbidity Donor selection 1 . Related donor compatible HLAA , B , C , DRB1 DQB1 molecular typing . Patient selection 1 . Cardiac insufficiency require treatment symptomatic coronary artery disease . 2 . Hepatic disease , AST &gt; 2 time normal . 3 . Severe hypoxaemia , pO2 &lt; 70 mm Hg , decrease DLCO &lt; 70 % predict ; mild hypoxemia , pO2 &lt; 80 mm Hg severely decrease DLCO &lt; 60 % predict . 4 . Impaired renal function ( creatinine &gt; 2 time upper limit normal creatinine clearance &lt; 50 % age , gender , weight ) . 5 . Patients receive previous treatment Thymoglobuline 6 . HIVpositive patient . 7 . Female patient pregnant breast feeding due risk foetus condition regimen potential risk nurse infant . 8 . Life expectancy severely limited disease MDS MPD . 9 . Serious concurrent untreated infection 10 . Patients limited life expectancy reason 11 . Serious psychiatric/ psychological disorder 12 . Absence /inability provide inform consent Donor selection 1 . Age &gt; 75 year , unless independently assess medically fit donate 2 . Donors reason unable tolerate leukapheresis procedure undergo anaesthesia marrow harvest . 3 . Donors HIVpositive , hepatitis B C PCR positive . 4 . Donors medically unsuitable donate</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2011</verification_date>
	<keyword>Myelodysplastic Syndromes</keyword>
	<keyword>Leukemia , Myeloid , Acute</keyword>
	<keyword>Haematopoietic stem cell transplantation</keyword>
	<keyword>Fludarabine</keyword>
	<keyword>Busulphan</keyword>
	<keyword>Thymoglobuline</keyword>
</DOC>